CLINICAL AND NEUROLOGICAL FEATURES OF HYPOTHERMIA IN CHILDREN

Hypothermia in children, defined as a fall in core body temperature below 35 °C, is usually associated with cold exposure, but in everyday pediatric practice it increasingly develops as a complication of drug treatment. In young children with acute respiratory viral infections, antipyretics (metamizole, paracetamol, ibuprofen), sedating antihistamines (diphenhydramine) and imidazoline nasal decongestants (naphazoline, xylometazoline, oxymetazoline) can lower body temperature and depress the central nervous system. Age-related features of the central nervous system, including incomplete maturation of thermoregulation and developmental differences in drug disposition and drug sensitivity, make children of early age, especially those aged 1–3 years, particularly vulnerable. This paper reviews literature published from 2000 to 2025 on the mechanisms of thermoregulation in children, the role of central nervous system immaturity, and the clinical-neurological manifestations, differential diagnosis and outcome of drug-associated hypothermia. The review shows that the neurological picture is dominated by depressed consciousness, ranging from drowsiness and lethargy to stupor and coma; that drug-associated hypothermia usually develops within hours after drug administration and resolves within 24 hours; and that it may mimic sepsis, central nervous system infection or poisoning.

Authors

Publication Details

Journal
HSR (London)
Published
2026-11-17
DOI
https://doi.org/10.5281/zenodo.24322605
Primary Topic
Thermal Regulation in Medicine
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

CLINICAL AND NEUROLOGICAL FEATURES OF HYPOTHERMIA IN CHILDREN

Worldly Knowledge Publishing Centre, Azimova N.M., Tashbaeva Sh.S.
HSR (London)
Thermal Regulation in Medicine
article

CLINICAL AND NEUROLOGICAL FEATURES OF HYPOTHERMIA IN CHILDREN

Worldly Knowledge Publishing Centre, Azimova N.M., Tashbaeva Sh.S.
article en

Abstract

Hypothermia in children, defined as a fall in core body temperature below 35 °C, is usually associated with cold exposure, but in everyday pediatric practice it increasingly develops as a complication of drug treatment. In young children with acute respiratory viral infections, antipyretics (metamizole, paracetamol, ibuprofen), sedating antihistamines (diphenhydramine) and imidazoline nasal decongestants (naphazoline, xylometazoline, oxymetazoline) can lower body temperature and depress the central nervous system. Age-related features of the central nervous system, including incomplete maturation of thermoregulation and developmental differences in drug disposition and drug sensitivity, make children of early age, especially those aged 1–3 years, particularly vulnerable. This paper reviews literature published from 2000 to 2025 on the mechanisms of thermoregulation in children, the role of central nervous system immaturity, and the clinical-neurological manifestations, differential diagnosis and outcome of drug-associated hypothermia. The review shows that the neurological picture is dominated by depressed consciousness, ranging from drowsiness and lethargy to stupor and coma; that drug-associated hypothermia usually develops within hours after drug administration and resolves within 24 hours; and that it may mimic sepsis, central nervous system infection or poisoning.

HSR (London)
Good health and well-being
Thermal Regulation in Medicine
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon